Cargando…
Ganciclovir-Resistant Cytomegalovirus Infection in a Kidney Transplant Recipient Successfully Treated with Foscarnet and Everolimus
Cytomegalovirus (CMV) infection remains a major cause of morbidity, graft failure, and death in kidney transplant recipients. We describe a case of a 53-year-old CMV-seronegative man who underwent renal transplant from a CMV-positive donor and who developed ganciclovir- (GCV-) resistant CMV infectio...
Autores principales: | Menghi, Viola, Comai, Giorgia, Baraldi, Olga, Liviano D'Arcangelo, Giovanni, Lazzarotto, Tiziana, La Manna, Gaetano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752979/ https://www.ncbi.nlm.nih.gov/pubmed/26942027 http://dx.doi.org/10.1155/2016/2736805 |
Ejemplares similares
-
Moving Past Ganciclovir and Foscarnet: Advances in CMV Therapy
por: Hakki, Morgan
Publicado: (2020) -
Everolimus-associated alveolar hemorrage relapse after drug discontinuation in a kidney transplant recipient
por: Busutti, Marco, et al.
Publicado: (2022) -
Successful Treatment of Epstein-Barr Virus-Induced Necrotizing Retinitis with Intravitreous Ganciclovir, Foscarnet, and Methotrexate
por: Cho, Junsang, et al.
Publicado: (2022) -
Foscarnet-Resistant Cytomegalovirus Esophagitis with Stricturing
por: Gaduputi, Vinaya, et al.
Publicado: (2013) -
Use of letermovir‐valganciclovir combination as a step‐down treatment after foscarnet for ganciclovir‐resistant CMV infection in kidney transplant recipients
por: Rho, Elena, et al.
Publicado: (2021)